BioSpace News Archive

Forge Biologics to Present at 40th Annual J.P. Morgan Healthcare Conference.

Prilenia Therapeutics B.V. today announced the completion of participant enrollment in the pridopidine arm of the HEALEY ALS Platform Trial.

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate at the J.P. Morgan Healthcare Conference on Monday, January 10, 2022.

Escient Pharmaceuticals today announced the appointment of Joshua Grass, MBA as Chief Executive Officer effective immediately.

Aeterna Zentaris Inc. announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna Zentaris, will present at the virtual H.C. Wainwright BioConnect Conference taking place January 10-13, 2022.

Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products for cancer patients, today announced that Praveen Tyle, Ph.D., Invectys Inc. President and CEO will participate in the JP Morgan Healthcare Meeting held virtually on January 10-13, 2022.

Aileron Therapeutics, a chemoprotection oncology company that aspires to develop medicines to make chemotherapy safer and thereby more effective to save more patients’ lives, provided a business update and outlined the company’s strategic priorities for 2022.

Armata Pharmaceuticals, Inc. announces the modification of its lead bacteriophage product candidate, AP-PA02, to include additional phage genera that increase potency and broaden coverage of strains of Pseudomonas aeruginosa found in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis.

Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced the appointment of David McIntyre as Chief Financial Officer.

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 11:15 am ET.